Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review
Overview
Authors
Affiliations
Background: Fecal immunochemical testing is the most commonly used method for colorectal cancer screening worldwide. However, its effectiveness is frequently undermined by failure to obtain follow-up colonoscopy after positive test results.
Purpose: To evaluate interventions to improve rates of follow-up colonoscopy for adults after a positive result on a fecal test (guaiac or immunochemical).
Data Sources: English-language studies from the Cochrane Central Register of Controlled Trials, PubMed, and Embase from database inception through June 2017.
Study Selection: Randomized and nonrandomized studies reporting an intervention for colonoscopy follow-up of asymptomatic adults with positive fecal test results.
Data Extraction: Two reviewers independently extracted data and ranked study quality; 2 rated overall strength of evidence for each category of study type.
Data Synthesis: Twenty-three studies were eligible for analysis, including 7 randomized and 16 nonrandomized studies. Three were at low risk of bias. Eleven studies described patient-level interventions (changes to invitation, provision of results or follow-up appointments, and patient navigators), 5 provider-level interventions (reminders or performance data), and 7 system-level interventions (automated referral, precolonoscopy telephone calls, patient registries, and quality improvement efforts). Moderate evidence supported patient navigators and provider reminders or performance data. Evidence for system-level interventions was low. Seventeen studies reported the proportion of test-positive patients who completed colonoscopy compared with a control population, with absolute differences of -7.4 percentage points (95% CI, -19 to 4.3 percentage points) to 25 percentage points (CI, 14 to 35 percentage points).
Limitation: More than half of studies were at high or very high risk of bias; heterogeneous study designs and characteristics precluded meta-analysis.
Conclusion: Patient navigators and giving providers reminders or performance data may help improve colonoscopy rates of asymptomatic adults with positive fecal blood test results. Current evidence about useful system-level interventions is scant and insufficient.
Primary Funding Source: National Cancer Institute. (PROSPERO: CRD42016048286).
Richter B, Roth S, Golzarri-Arroyo L, Kumar V, Tuason R, Imperiale T Prev Med Rep. 2024; 49:102937.
PMID: 39691357 PMC: 11648236. DOI: 10.1016/j.pmedr.2024.102937.
Leblanc V, Hamroun A, Bentegeac R, Le Guellec B, Lenain R, Chazard E J Med Internet Res. 2024; 26:e53781.
PMID: 39561364 PMC: 11615561. DOI: 10.2196/53781.
Subramanian S, Tangka F, Hoover S, Mathews A, Redwood D, Smayda L Cancer Causes Control. 2024; 35(11):1467-1476.
PMID: 39107449 PMC: 11670815. DOI: 10.1007/s10552-024-01898-w.
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.
Alagoz O, May F, Doubeni C, Fendrick A, Vahdat V, Estes C J Natl Cancer Inst. 2024; 116(11):1807-1816.
PMID: 39044335 PMC: 11542987. DOI: 10.1093/jnci/djae140.
Price D, Brain K, Dolwani S, Edwards A, Hood K, Smits S Health Expect. 2024; 27(4):e14126.
PMID: 38952213 PMC: 11217598. DOI: 10.1111/hex.14126.